Fallas SM

Idioma: Español
Referencias bibliográficas: 20
Paginas: 89-92
Archivo PDF: 207.93 Kb.

RESUMEN

La esclerosis lateral amiotrófica es una enfermedad neurológica progresiva cuya causa aún es desconocida. La enfermedad afecta los músculos de control voluntario y la mayoría de pacientes muere de fallo respiratorio en los siguientes 3 a 5 años de la aparición de los síntomas. Aún no se ha encontrado un tratamiento efectivo para su cura, pero gracias a los avances tecnológicos hay mejoría de la sintomatología y en la calidad de vida de los pacientes. Este artículo incluye una revisión de los aspectos más importantes de la enfermedad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Boilee S, Vande V, Cleveland D: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006; 52 (1): 39-59.

2. Brooks B, Miller R, Swash M et al: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Motor Neuron Disord. 2000; 1(5): 293-299.

3. Bruijn L, Miller T, Cleveland D: Unraveling the mechanism involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723-749.

4. Chen Y, Bennet C, Huyhn H: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis. Am j Hum Genet. 2004; 73(2):390-396.

5. Greenway M, Andersen P, Russ C: ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis. Nat Genet. 2006; 38(4):411-413.

6. Hand C, Khoris J, Salachas F: A novel locus for familial amyotrophic lateral sclerosis on chromosome 18q. Am J Hum Genet. 2002; 70(1):251-256.

7. Hosler B, Siddique T, Sapp P: Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia. JAMA. 2000; 284(13):1664-1669.

8. Houseman G: Symptom Management of the Patient with Amyotrophic Lateral Sclerosis. Journal of Hospice and Palliative Nursing. 2008; 10(4):214-215.

9. Kurt A, Nijboer F, Matuz T et al: Depression and anxiety in individual with amyotrophic lateral sclerosis: epidemiology and management. CNS drugs. 2007; 21(4):279-291.

10. Kwong L, Neumann M, Sampathu D et al: The neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration motor neuron disease. Acta Neuropathol. 2007; 114:63-70.

11. Lomen C: Amyotrophic lateral sclerosis from bench to bedside. Semin Neurol. 2008; 28(2):205-211.

12. Mackenzie I, Bigio E, Ince P: Pathological TDP 43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007; 61(5):427-434.

13. Miller R, Rosenberg J, Gelinas D: Practice Parameter: the care of the patient with amyotrophic lateral sclerosis. Neurology. 1999; 2(7) 1311-1323.

14. Morita M, al. Chalabi A, Andersen P: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology . 2006; 66(6):839-844.

15. Murphy J, Henry R, Lomen-Hoerth C: Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol, 2007; 64(3):330-334.

16. Neary D, Snowden J, Mann D: Cognitive change in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci. 2000; 180(1-2):15-20.

17. Rabkin J, Albert S, Del Bene M: Prevalence of depressive disorders and change over the time in late stage ALS. Neurology. 2005; 65(1):62-67.

18. Rowland P. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998; 160(1):s6-s24.

19. Ruddy D, Parton M: Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Genet. 2004; 74(6):1128-1135.

20. Sapp P, Hosler B, McKenna Yasek M: Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet. 2003; 73(2):390-396.